Modest dose anti-thymocyte globulin administered intraoperatively is safe and effective in kidney transplantations: a retrospective study.
Hui-Ying LiuYuan Tso ChengHao-Lun LuoChiang-Chi HuangChien Hsu ChenYuan-Chi ShenWen-Chin LeePublished in: PeerJ (2019)
In recent years, a trend of using a "lower" dose of ATG has seemed to emerge. Our results suggest intraoperative modest-dose ATG followed by daily low-dose ATG regimen was safe and effective in cadaveric renal transplantations for preventing DGF, AR, and graft loss.